https://www.pharmanow.live/latest-news/hepion-pharmaceuticals-fda-gv104-gambling-disorder-505b2-pathway 2026-10-21T11:19:43+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Hepion Gains FDA Guidance for GV104 Gambling Disorder Trial Hepion https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/hepion-gv104-fda-guidance-gambling-disorder-phase-2-trial-202620261021111649.webp https://www.pharmanow.live/latest-news/fda-pediatric-advisory-committee-september-2026-meeting-materials-biologics 2026-10-21T11:13:12+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 FDA Posts September 2026 Pediatric Advisory Committee Materials FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-pediatric-advisory-committee-september-2026-meeting-materials20261021111047.webp https://www.pharmanow.live/latest-news/dogwood-therapeutics-secures-5-million-ck-life-sciences-halneuron-phase-3-preparation 2026-10-21T11:07:00+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Dogwood Therapeutics Secures $5M for Halneuron Phase 3 Prep Dogwood https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/dogwood-therapeutics-5m-ck-life-sciences-halneuron-phase-3-202620261021110547.webp https://www.pharmanow.live/latest-news/cormica-surrogate-molecule-hplc-dual-detection-potent-compound-classification 2026-10-19T21:57:25+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Cormica Develops Dual-Detection HPLC Method for Potent API Classification Cormica https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/06/Naproxen-Article-Banner-Image-600x200.png https://www.pharmanow.live/latest-news/insmed-launches-brinsupri-japan-mhlw-approval-ncfb 2026-10-21T11:01:30+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Insmed Launches BRINSUPRI in Japan for NCFB Patients Aged 12+ Insmed https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/insmed-brinsupri-japan-launch-ncfb-treatment-202620261021110022.webp https://www.pharmanow.live/latest-news/abbvie-abbv-466-dual-targeting-phase-2a-crohns-endoscopic-remission 2026-10-21T10:56:00+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 AbbVie ABBV-466 Shows 40.5% Endoscopic Remission in Crohn’s Trial AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie-abbv-466-phase-2a-crohns-endoscopic-remission-202620261021105541.webp https://www.pharmanow.live/latest-news/thermo-fisher-cphi-milan-2026 2026-10-19T15:48:41+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Thermo Fisher CPHI Milan 2026: Drug Development Expansion Thermo Fisher CPHI Milan 2026, Thermo Fisher drug development, OSD Express, Steriles Express Solutions, KinetiSol Technology, AustinPx, sterile manufacturing https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/thermo-fisher-cphi-milan-202620261019154441.webp https://www.pharmanow.live/latest-news/telix-ekalia-astatine-211-production-us-rls-network 2026-10-21T10:48:54+05:30 Pharma Now en 2026-10-19T00:00:00+05:30 Telix and Ekalia Partner to Expand U.S. Astatine-211 Production Telix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/telix-ekalia-astatine-211-us-production-202620261021104848.webp